• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过哺乳动物α-葡萄糖苷酶催化的转糖基化反应形成稳定的L-抗坏血酸α-葡萄糖苷。

Formation of a stable L-ascorbic acid alpha-glucoside by mammalian alpha-glucosidase-catalyzed transglucosylation.

作者信息

Yamamoto I, Muto N, Nagata E, Nakamura T, Suzuki Y

机构信息

Department of Immunochemistry, Faculty of Pharmaceutical Sciences, Okayama University, Japan.

出版信息

Biochim Biophys Acta. 1990 Jul 20;1035(1):44-50. doi: 10.1016/0304-4165(90)90171-r.

DOI:10.1016/0304-4165(90)90171-r
PMID:2200520
Abstract

Enzymatic transglucosylation from maltose to L-ascorbic acid (AA) with mammalian tissue homogenates was determined by a high-performance liquid chromatography method and compared with the reaction catalyzed by alpha-glucosidase from Aspergillus niger. The homogenates of small intestine and kidney had a high transglucosylase activity to form a new type of glucosylated AA, which was associated with alpha-glucosidase activity. The new compound was demonstrated to be an equimolar conjugate of AA and glucose by the spectral and quantitative analyses. In particular, it showed a high stability in a neutral solution and no reducing activity toward cytochrome c and a dye. These properties were very different from those of AA and L-ascorbic acid alpha-glucoside formed with alpha-glucosidase from A. niger, but they were consistent with those of L-ascorbic acid 2-O-phosphate and L-ascorbic acid 2-O-sulfate. Moreover, it exhibited a reducing power associated with AA after mild acid hydrolysis or treatment with rat intestinal alpha-glucosidase. These results indicate that it should be assigned the 2-O-alpha-glucoside structure. Consequently, it is concluded that mammalian alpha-glucosidase is able to form a very stable and nonreducing form of glucosylated AA through a specific transglucosylation reaction distinct from that of microbial alpha-glucosidase.

摘要

采用高效液相色谱法测定了麦芽糖与L-抗坏血酸(AA)在哺乳动物组织匀浆中的酶促转葡糖基化反应,并与黑曲霉α-葡糖苷酶催化的反应进行了比较。小肠和肾脏匀浆具有较高的转葡糖基酶活性,可形成一种新型的糖基化AA,这与α-葡糖苷酶活性有关。通过光谱和定量分析表明,新化合物是AA与葡萄糖的等摩尔共轭物。特别是,它在中性溶液中表现出高稳定性,对细胞色素c和一种染料没有还原活性。这些性质与用黑曲霉α-葡糖苷酶形成的AA和L-抗坏血酸α-葡糖苷的性质非常不同,但与L-抗坏血酸2-O-磷酸酯和L-抗坏血酸2-O-硫酸酯的性质一致。此外,在温和酸水解或用大鼠肠道α-葡糖苷酶处理后,它表现出与AA相关的还原能力。这些结果表明它应具有2-O-α-葡糖苷结构。因此,可以得出结论,哺乳动物α-葡糖苷酶能够通过一种不同于微生物α-葡糖苷酶的特异性转葡糖基化反应,形成一种非常稳定且无还原活性的糖基化AA形式。

相似文献

1
Formation of a stable L-ascorbic acid alpha-glucoside by mammalian alpha-glucosidase-catalyzed transglucosylation.通过哺乳动物α-葡萄糖苷酶催化的转糖基化反应形成稳定的L-抗坏血酸α-葡萄糖苷。
Biochim Biophys Acta. 1990 Jul 20;1035(1):44-50. doi: 10.1016/0304-4165(90)90171-r.
2
Enzymatic formation of a nonreducing L-ascorbic acid alpha-glucoside: purification and properties of alpha-glucosidases catalyzing site-specific transglucosylation from rat small intestine.非还原性L-抗坏血酸α-葡萄糖苷的酶促合成:催化大鼠小肠位点特异性转糖基化反应的α-葡萄糖苷酶的纯化及性质
J Biochem. 1990 Feb;107(2):222-7. doi: 10.1093/oxfordjournals.jbchem.a123030.
3
Evidence for the in vivo formation of ascorbic acid 2-O-alpha-glucoside in guinea pigs and rats.
Biochem Pharmacol. 1991 Jul 15;42(3):625-31. doi: 10.1016/0006-2952(91)90326-z.
4
L-ascorbic acid alpha-glucoside formed by regioselective transglucosylation with rat intestinal and rice seed alpha-glucosidases: its improved stability and structure determination.
Chem Pharm Bull (Tokyo). 1990 Nov;38(11):3020-3. doi: 10.1248/cpb.38.3020.
5
Antiscorbutic activity of L-ascorbic acid 2-glucoside and its availability as a vitamin C supplement in normal rats and guinea pigs.L-抗坏血酸2-葡萄糖苷的抗坏血病活性及其作为维生素C补充剂在正常大鼠和豚鼠体内的可利用性。
J Pharmacobiodyn. 1990 Nov;13(11):688-95. doi: 10.1248/bpb1978.13.688.
6
Bioavailability of a series of novel acylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as an ascorbic acid supplement in rats and guinea pigs.一系列新型酰化抗坏血酸衍生物,即6-O-酰基-2-O-α-D-吡喃葡萄糖基-L-抗坏血酸,在大鼠和豚鼠体内作为抗坏血酸补充剂的生物利用度。
Biosci Biotechnol Biochem. 2002 Aug;66(8):1628-34. doi: 10.1271/bbb.66.1628.
7
Characterization of Bacillus stearothermophilus cyclodextrin glucanotransferase in ascorbic acid 2-O-alpha-glucoside formation.嗜热脂肪芽孢杆菌环糊精葡糖基转移酶在抗坏血酸2-O-α-葡糖苷形成中的特性研究
Biochim Biophys Acta. 1991 Jun 24;1078(2):127-32. doi: 10.1016/0167-4838(91)99000-1.
8
Intramolecular acyl migration and enzymatic hydrolysis of a novel monoacylated ascorbic acid derivative, 6-O-dodecanoyl-2-O-alpha-d-glucopyranosyl-L-ascorbic acid.新型单酯化抗坏血酸衍生物 6-O-十二烷酰基-2-O-α-D-吡喃葡萄糖基-L-抗坏血酸的分子内酰基迁移和酶水解。
Bioorg Med Chem. 2010 Aug 15;18(16):6179-83. doi: 10.1016/j.bmc.2010.06.027. Epub 2010 Jun 12.
9
Evaluation of ascorbic acid 2-O-alpha-glucoside as vitamin C source: mode of intestinal hydrolysis and absorption following oral administration.抗坏血酸2-O-α-葡萄糖苷作为维生素C来源的评估:口服后的肠道水解和吸收模式
Int J Vitam Nutr Res. 1992;62(4):318-23.
10
Synthesis and characterization of a series of novel monoacylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as skin antioxidants.一系列新型单酰化抗坏血酸衍生物,即6-O-酰基-2-O-α-D-吡喃葡萄糖基-L-抗坏血酸作为皮肤抗氧化剂的合成与表征。
J Med Chem. 2002 Jan 17;45(2):462-8. doi: 10.1021/jm010379f.

引用本文的文献

1
Antiallergic Activity of 6-Deoxy-2--methyl-6-(-hexadecanoyl)amino-l-ascorbic Acid.6-脱氧-2-O-甲基-6-(-己十六酰基)氨基-L-抗坏血酸的抗过敏活性。
Molecules. 2021 Aug 3;26(15):4684. doi: 10.3390/molecules26154684.
2
Chemoenzymatic Approach toward the Synthesis of 3--(α/β)-Glucosylated 3-Hydroxy-β-lactams.化学酶法合成3-(α/β)-葡萄糖基化3-羟基-β-内酰胺
ACS Omega. 2018 Nov 30;3(11):15235-15245. doi: 10.1021/acsomega.8b01969. Epub 2018 Nov 12.
3
Eliminating hydrolytic activity without affecting the transglycosylation of a GH1 β-glucosidase.
在不影响GH1 β-葡萄糖苷酶转糖基化作用的情况下消除水解活性。
Appl Microbiol Biotechnol. 2017 Feb;101(3):1121-1131. doi: 10.1007/s00253-016-7833-9. Epub 2016 Sep 27.
4
Glucansucrase Gtf180-ΔN of Lactobacillus reuteri 180: enzyme and reaction engineering for improved glycosylation of non-carbohydrate molecules.罗伊氏乳杆菌180的葡聚糖蔗糖酶Gtf180-ΔN:用于改善非碳水化合物分子糖基化的酶与反应工程
Appl Microbiol Biotechnol. 2016 Sep;100(17):7529-39. doi: 10.1007/s00253-016-7476-x. Epub 2016 Apr 6.
5
Engineering a Carbohydrate-processing Transglycosidase into Glycosyltransferase for Natural Product Glycodiversification.将碳水化合物加工转糖基酶工程改造为糖基转移酶用于天然产物糖基多样化
Sci Rep. 2016 Feb 12;6:21051. doi: 10.1038/srep21051.
6
Drug nanoparticle formulation using ascorbic Acid derivatives.使用抗坏血酸衍生物的药物纳米颗粒制剂
J Drug Deliv. 2011;2011:138929. doi: 10.1155/2011/138929. Epub 2011 Apr 26.
7
Novel alpha-glucosidase from Aspergillus nidulans with strong transglycosylation activity.来自构巢曲霉的具有强转糖基化活性的新型α-葡萄糖苷酶。
Appl Environ Microbiol. 2002 Mar;68(3):1250-6. doi: 10.1128/AEM.68.3.1250-1256.2002.